The United States has included India, China and Pakistan in its FY2027 list of major drug transit or illicit drug-producing countries. Being listed does not by itself imply a failure to curb trafficking, since geography, trade and economic factors are considered. The US acknowledged India's action against illicit opium cultivation, tighter supply-chain controls and cooperation under the U.S.-India Drug Policy Framework. China was flagged as a key source of precursor chemicals for fentanyl, methamphetamine and other synthetic drugs, while Afghanistan, Bolivia, Burma (Myanmar) and Colombia were said to have "failed demonstrably" on counternarcotics obligations.